secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001493152-26-008169
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insight Molecular Diagnostics enters specimen collection pact with Quest for GraftAssureCore test
--------------------------------------------------------------------------------

- Agreement with Quest Diagnostics dated Feb 20, 2026 for specimen collection services related to GraftAssureCore dd-cfDNA test.
- Quest will provide services for the PCR-based blood test measuring donor-derived cell free DNA.
- Parties also agree to negotiate additional rights to GraftAssure technology for a specified period.
- Specific fees and financial terms not disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226008169/0001493152-26-008169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315226008169/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer